Treatment of Benign Prostatic Hyperplasia

Transurethral microwave thermotherapy, visual laser ablation with the Nd:YAG laser, high-intensity focused ultrasound, and transurethral electrovaporization are some of the techniques described in this book.

Treatment of Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is an age-related, nonmalignant condition that may lead to bothersome lower urinary tract symptoms. The standard treatment of BPH has been ordinary loop transurethral prostatectomy, but new therapies have been developed as a combined result of research, technological advances, and the cumulative experience of urological surgeons. Among the most promising therapeutic alternatives to ordinary loop resection are those that deliver topical or interstitial heat to prostatic tissue. Transurethral microwave thermotherapy, visual laser ablation with the Nd:YAG laser, high-intensity focused ultrasound, and transurethral electrovaporization are some of the techniques described in this book. These innovative procedures, employed by skilled urologists using state-of-the-art instruments, hold forth the promise of improved quality of life for BPH patients and represent significant advances in the field of urology.

More Books:

Treatment of Benign Prostatic Hyperplasia
Language: en
Pages: 200
Authors: K. Koshiba, M. Miki, T. Terachi, T. Uchida
Categories: Medical
Type: BOOK - Published: 2012-12-06 - Publisher: Springer Science & Business Media

Benign prostatic hyperplasia (BPH) is an age-related, nonmalignant condition that may lead to bothersome lower urinary tract symptoms. The standard treatment of BPH has been ordinary loop transurethral prostatectomy, but new therapies have been developed as a combined result of research, technological advances, and the cumulative experience of urological surgeons.
Alternate Methods in the Treatment of Benign Prostatic Hyperplasia
Language: en
Pages: 205
Authors: Nicholas A. Romas, E.Darracott Vaughan
Categories: Medical
Type: BOOK - Published: 2012-12-06 - Publisher: Springer Science & Business Media

For many years, patients who complained of prostatism had only a few treatment choices. The patient was either a candidate for an elective prostatectomy, or the operation was deferred until the patient became more symptomatic. The present text summarizes the multiple options which have become available to the practicing urologist.
Benign Prostatic Hyperplasia
Language: en
Pages: 198
Authors: Gerhard Jakse, Christian Bouffioux, Jean de Leval, Rudi A. Janknegt
Categories: Medical
Type: BOOK - Published: 2012-12-06 - Publisher: Springer Science & Business Media

An intense discussion has recently begun regarding current standards in the diagnosis and treatment of benign prosta tic hyperplasia (BPH). A number of factors have led to this discussion. In an increasing proportion of aging men, for example, BPH causes so-called obstructive symptoms that must be relieved by medical or
Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate
Language: en
Pages: 172
Authors: Bilal Chughtai, Alexis E. Te, Steven A. Kaplan
Categories: Medical
Type: BOOK - Published: 2014-10-06 - Publisher: Springer

Treatment of Benign Prostatic Hyperplasia: Modern Techniques is an up-to-date review of modern techniques used to treat benign prostatic hyperplasia. It provides a comprehensive review of both office and operating room based techniques. Both electrosurgical and laser based techniques are covered. These include high powered 532 nm laser photoselective laser
Management of Benign Prostatic Hypertrophy
Language: en
Pages: 269
Authors: Kevin T. McVary
Categories: Medical
Type: BOOK - Published: 2003-11-25 - Publisher: Springer Science & Business Media

A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations.